Remove Mayo Clinic Remove Specialty Pharmacies Remove Vaccines
article thumbnail

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Drug Topics

Mayo Clinic Staff. Mayo Clinic. link] Newsletter Pharmacy practice is always changing. The impact of pharmacist-led interventions on the treatment of COPD patients. Med Princ Pract. 2025; [link] 2. What is COPD? National Heart, Lung, and Blood Institute. November 8, 2024. Accessed July 17, 2025. August 30, 2024.

article thumbnail

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

In an interview with Pharmacy Times at the 2025 Oncology Pharmacists Connect (OPC) meeting, Scott Soefje, PharmD, MBA, BCOP, director of pharmacy at Mayo Clinic, focused on the evolving role of pharmacists in healthcare, highlighting their increasing presence in outpatient settings to enhance efficiency and patient care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Pharmacy Times

Mayo Clinic. Pharmacy Times. RAD 2025: Long-term data on Nemluvio® (nemolizumab) demonstrate its favorable safety profile and sustained and increased improvements in itch and skin lesions in patients with atopic dermatitis up to two years. News release. June 6, 2025. Accessed June 16, 2025. Atopic Dermatitis. News release.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

This act…allowed a pathway for manufacturers to create a ‘copy’ of a licensed patent product to make it cheaper and more discounted,” Soefje, director of pharmacy cancer care services and associate professor of pharmacy at Mayo Clinic in Rochester, Minnesota, said at the HOPA conference.

FDA 65
article thumbnail

Immunotherapy Takes the Lead in Advanced Cutaneous Malignancies

Pharmacy Times

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

article thumbnail

FDA Approves Y-90 Resin Microspheres for Unrespectable Hepatocellular Carcinoma

Pharmacy Times

Mayo Clinic. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Sirtex Medical’s SIR-Spheres ® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma.

FDA 50
article thumbnail

Pharmacists Take the Lead on Advanced Therapeutics

Pharmacy Times

Still, confusion remains over the role of pharmacy and therapeutics (P&T) committees in this process. Tichy, PharmD, MBA, vice chair of pharmacy formulary for Mayo Clinic, explained. This governance issue is a very hot topic,” Eric M.